GILD Competitors & Alternatives
Compare Gilead Sciences Inc with similar stocks in the same industry
Drug Manufacturers - General
GILD
Main Stock$147.60
Tradestie Score
45
Market Cap
$137.92B
Revenue Growth
0.1%
Analyst Upside
+6.6%
Top Competitors
17 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVO
Novo-Nordisk A/S
|
$46.48
|
$262.92B | 11.3 | 51 | Compare |
|
AZN
AstraZeneca PLC
|
$164.95
|
$261.56B | 23.5 | 69 | Compare |
|
NVS
Novartis AG
|
$160.31
|
$254.99B | 22.8 | 49 | Compare |
|
MRK
Merck & Co., Inc.
|
$152.20
|
$225.13B | 108.8 | 41 | Compare |
|
AMGN
Amgen Inc
|
$442.36
|
$160.70B | 26.0 | 40 | Compare |
|
PFE
Pfizer Inc.
|
$28.24
|
$154.70B | 35.3 | 39 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$45.83
|
$121.27B | 23.4 | 38 | Compare |
|
BMY
Bristol-Myers Squibb Co.
|
$67.61
|
$96.54B | 14.2 | 39 | Compare |
|
GSK
GSK plc American Depositary Shares (Each representing two Ordinary Shares)
|
$52.88
|
$91.59B | 15.6 | 51 | Compare |
|
REGN
Regeneron Pharmaceuticals Inc
|
$840.84
|
$63.59B | 19.7 | 36 | Compare |
More GILD Analysis
Data updated: Aug 19, 2026 | Industry: Drug Manufacturers - General (SIC 2836)
17 stocks in this industry